The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

T-Cell Large Granular Lymphocytic Leukemia: Immunosuppressive Therapy

Indolent T-cell clonal disorder with cytopenia management

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is T-Cell Large Granular Lymphocytic Leukemia: Immunosuppressive Therapy?

T-LGL leukemia is characterized by clonal expansion of CD3-positive cytotoxic T cells with characteristic morphology.

STAT3 activating mutations present in 30 to 40 percent of cases driving constitutive proliferation.

Strongly associated with autoimmune conditions, especially rheumatoid arthritis (Felty syndrome variant).

Cytopenias (neutropenia, anemia, thrombocytopenia) drive symptoms and treatment decisions.

Indolent course in most patients; some have aggressive disease requiring intensification.

Symptoms

Recurrent infections from chronic neutropenia.
Fatigue and pallor from anemia, often pure red cell aplasia phenotype.
Splenomegaly in approximately 50 percent of patients.
Joint pain and synovitis from associated rheumatoid arthritis.
Bleeding tendency in patients with thrombocytopenia.

Risk Factors

Coexisting rheumatoid arthritis or other autoimmune disorders.
STAT3 mutation increases responsiveness to JAK-STAT-directed therapies.
Severe persistent neutropenia (less than 500 per microliter) drives infection risk.
Pure red cell aplasia phenotype requires distinction from other causes.
Older age at diagnosis (median 60 years).

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Recurrent or severe infections in setting of unexplained neutropenia.
  • Worsening fatigue, dyspnea on exertion, or pallor suggesting anemia.
  • Persistent cytopenia not responding to growth factors.
  • Bleeding episodes or unusual bruising.
  • New autoimmune symptoms during follow-up.

Treatment Methods

01
Asymptomatic patients with mild cytopenias may be observed initially.
02
Methotrexate 10 mg orally weekly is first-line for symptomatic cytopenia.
03
Cyclophosphamide 50 to 100 mg orally daily as alternative or second-line.
04
Cyclosporine A as third-line option for refractory cytopenias.
05
JAK inhibitors and ruxolitinib under investigation in STAT3-mutated cases.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.